What are the risks and side effects of starting TRT in your 30s?

Short answer up front

• The biggest specific concerns for someone starting testosterone replacement therapy (TRT) in their 30s are suppression of fertility (reduced sperm production), testicular atrophy, increased red blood cell mass (polycythemia) with clot risk, possible effects on mood and sleep apnea, and uncertain long‑term cardiovascular effects. Prostate cancer is a contraindication to treatment (and TRT can make an existing prostate cancer worse), but TRT is not clearly proven to cause prostate cancer.

Common and expected side effects

• Acne, oily skin, and increased facial/body hair.
• Scalp hair loss (can accelerate male‑pattern baldness).
• Increased libido, possible irritability or mood swings, occasionally aggression.
• Small risk of fluid retention and worsening of sleep apnea.
• Testicular shrinkage and decreased natural testosterone production (due to suppression of LH/FSH).
• Gynecomastia from aromatization of testosterone to estradiol in some men.

More serious / less common risks

• Fertility loss: Exogenous testosterone suppresses the hypothalamic‑pituitary‑gonadal axis, lowering LH/FSH and often markedly reducing sperm counts; this can lead to temporary or (rarely) prolonged infertility. Recovery often takes several months to >1 year after stopping TRT, and sometimes requires medical help.
• Polycythemia (high hematocrit): TRT commonly raises hemoglobin/hematocrit; Hct >52% increases risk of blood clots, stroke, and heart attack. Monitoring and therapeutic phlebotomy or dose adjustment may be needed.
• Cardiovascular events: data are mixed. Some studies found increased risk of major adverse cardiovascular events (MACE) in certain groups; other studies found no increase. Long‑term risk, especially with decades of therapy starting in your 30s, is not fully known.
• Prostate: TRT can increase PSA and stimulate growth of existing prostate cancer — therefore baseline screening (PSA ± DRE) and ongoing monitoring are required. TRT is contraindicated with known or suspected prostate or breast cancer.
• Liver toxicity: mainly a concern with older oral 17‑alpha‑alkylated androgens (rarely used today). Modern gels, patches, injections are not typically hepatotoxic.

What to check before and during TRT

• Baseline: two morning total testosterone measurements (ideally), LH/FSH, prolactin (if low T), CBC (hematocrit/hemoglobin), PSA, lipid panel, fasting glucose or HbA1c, liver tests, and a baseline semen analysis if you want future fertility.
• Monitoring after starting: testosterone level 2–12 weeks after starting or changing dose, CBC/Hct at 3 months then every 6–12 months, PSA at 3–6 months then annually (age and risk dependent), symptom review, blood pressure and sleep apnea screening as indicated.
• Frequency and specific testing depend on formulation and clinical situation — do this with the doctor who prescribes TRT.

Fertility-preserving options and alternatives

• If you want biological children now or in the future, discuss alternatives before starting:
  • Use gonadotropin therapy (hCG, brand examples: Pregnyl or Ovidrel for some uses) or selective estrogen receptor modulators like clomiphene (Clomid) to raise endogenous testosterone while maintaining spermatogenesis in many men.
  • Enclomiphene (Androxal) is another option in some places.
  • Sperm banking prior to starting TRT is a straightforward way to preserve fertility.
  • If you need symptom control but want to keep fertility, an endocrinologist or reproductive urologist can design a plan.
• Note: switching from TRT to fertility‑sparing regimens can take time and may not fully restore sperm counts immediately.

Choices of TRT formulations (pros/cons)

• Topical gels: AndroGel, Testim — steady daily dosing, easier to titrate; risk of transfer to partners/children if contact occurs.
• Patches: Androderm — steady delivery, but skin irritation common.
• Short‑acting intramuscular injections: testosterone cypionate (Depo‑Testosterone) — inexpensive, but cause peaks/troughs and sometimes mood swings.
• Long‑acting intramuscular injections: testosterone undecanoate (Aveed in the U.S., Nebido in Europe) — fewer injections, steadier levels.
• Each formulation differs in convenience, cost, side effects, monitoring needs, and absorption variability.

When TRT is not appropriate

• Active prostate or breast cancer, very high baseline hematocrit, and some cases of severe heart failure are contraindications. Also be cautious if you have untreated severe sleep apnea or uncontrolled cardiovascular disease.

Practical next steps and risk mitigation

• Don’t start TRT without a full evaluation. See a knowledgeable clinician: a primary care doctor experienced in men’s health, an endocrinologist, or a urologist (reproductive/urologic) if fertility is a concern.
• Get baseline labs and a semen analysis if you may want kids.
• Use the lowest effective dose and monitor hematocrit, testosterone, PSA, lipids, and symptoms.
• Consider sperm banking or fertility‑preserving medical strategies (hCG, clomiphene) if you want children.
• Address reversible causes of low T first (weight loss, sleep, treatment of medications like opioids, control of chronic illness).

Services and brands (practical recommendations)

• Lab testing: LabCorp or Quest Diagnostics — widely available and accepted by physicians for the baseline and monitoring tests listed above.
• TRT products: AndroGel and Testim (gels) for steady daily dosing; Androderm (patches) if you prefer patches; Depo‑Testosterone (testosterone cypionate) for standard injections; Aveed (testosterone undecanoate) for long‑acting injection if you want fewer injections. Discuss pros/cons with your clinician.
• For fertility preservation or counseling: consult a reproductive urologist or local fertility clinic (look for SART member clinics in the U.S.).
• Telehealth/consumer TRT services: companies such as Hims or Roman provide convenient evaluation and delivery, but they vary in scope — for complex issues (fertility concerns, prior cancers, cardiovascular disease) prefer an in‑person specialist.

Bottom line TRT can relieve symptoms in men with truly low testosterone, but starting it in your 30s carries special considerations—especially fertility suppression and long‑term unknowns about cardiovascular risk with decades of exposure. Before starting, get a careful evaluation, baseline tests (including semen analysis if fertility matters), discuss fertility‑preserving options, and agree on a monitoring plan with an experienced clinician.

If you’d like, tell me your symptoms, the lab numbers (morning total testosterone, LH/FSH, Hct/Hb, PSA if done), and whether you want future children — I can help you interpret results and suggest next steps.